ArticleCurrent pharmaceutical design2022

State-of-the-art Tools to Elucidate the Therapeutic Potential of TAT-peptide (TP) Conjugated Repurposing Drug Against SARS-CoV-2 Spike Glycoproteins.

Mohammad Azam Ansari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.